Literature DB >> 11049735

Neurokinin mediation of edema and inflammation.

M M Campos1, J B Calixto.   

Abstract

The aim of this article is to furnish a brief review of the role played by neurokinins in the inflammatory process. Further attention is given to the mechanisms, as well as to the receptor subtypes involved in neurokinin-mediated inflammation, in an attempt to clarify the participation of neurokinins in different models of acute and chronic inflammation. The involvement of SP, NKA and NKB is also examined in relation to the major signs of inflammation, including edema formation, protein plasma extravasation and vasodilatation. Finally, we provide a general overview on the potential clinical applications of neurokinin antagonists, along with the involvement of neurokinins in human diseases. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049735     DOI: 10.1054/npep.2000.0823

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  19 in total

1.  Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture.

Authors:  Gert Zimmer; Karl-Klaus Conzelmann; Georg Herrler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 2.  Respiratory mechanics in brain injury: A review.

Authors:  Antonia Koutsoukou; Maria Katsiari; Stylianos E Orfanos; Anastasia Kotanidou; Maria Daganou; Magdalini Kyriakopoulou; Nikolaos G Koulouris; Nikoletta Rovina
Journal:  World J Crit Care Med       Date:  2016-02-04

3.  Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Brittany Straka; Hui Nian; Chantel Sloan; James Brian Byrd; Alencia Woodard-Grice; Chang Yu; Elizabeth Stone; Gary Steven; Tina Hartert; Koon K Teo; Guillaume Pare; Catherine A McCarty; Nancy J Brown
Journal:  J Allergy Clin Immunol Pract       Date:  2013-06-21

4.  Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Alencia V Woodard-Grice; Amelia C Lucisano; James B Byrd; Elizabeth R Stone; William H Simmons; Nancy J Brown
Journal:  Pharmacogenet Genomics       Date:  2010-09       Impact factor: 2.089

5.  Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke.

Authors:  S T Engelter; F Fluri; C Buitrago-Téllez; S Marsch; A J Steck; S Rüegg; P A Lyrer
Journal:  J Neurol       Date:  2005-09-27       Impact factor: 4.849

6.  Respiratory mechanics in brain-damaged patients.

Authors:  Antonia Koutsoukou; Helen Perraki; Asimina Raftopoulou; Nikolaos Koulouris; Christina Sotiropoulou; Anastasia Kotanidou; Stylianos Orfanos; Charis Roussos
Journal:  Intensive Care Med       Date:  2006-10-20       Impact factor: 17.440

7.  Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms.

Authors:  Andrew D Grant; Roksana Akhtar; Norma P Gerard; Susan D Brain
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

8.  Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.

Authors:  James Brian Byrd; Karine Touzin; Saba Sile; James V Gainer; Chang Yu; John Nadeau; Albert Adam; Nancy J Brown
Journal:  Hypertension       Date:  2007-11-19       Impact factor: 10.190

Review 9.  Clinical Immunology Review Series: An approach to the patient with angio-oedema.

Authors:  S Grigoriadou; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

10.  Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.

Authors:  Nancy J Brown; Stuart Byiers; David Carr; Mario Maldonado; Barbara Ann Warner
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.